- Home
- IRT vs CORT Comparison
IRT vs CORT Comparison
Compare IRT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRT | CORT |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | IRT | CORT |
|---|---|---|
| Price | $16.82 | $44.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $21.72 | ★ $114.20 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.09 | ★ 0.87 |
| Revenue | $662,924,000.00 | ★ $741,172,000.00 |
| Revenue This Year | $4.29 | $21.70 |
| Revenue Next Year | $4.54 | $30.13 |
| P/E Ratio | $184.80 | ★ $50.35 |
| Revenue Growth | 3.19 | ★ 17.92 |
| 52 Week Low | $15.07 | $32.99 |
| 52 Week High | $21.87 | $117.33 |
Technical Indicators
Market Signals| Indicator | IRT | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 40.15 |
| Support Level | $16.55 | $34.06 |
| Resistance Level | $17.23 | $37.48 |
| Average True Range (ATR) | 0.38 | 2.03 |
| MACD | -0.08 | 1.33 |
| Stochastic Oscillator | 24.55 | 94.99 |
Price Performance
Historical ComparisonAbout IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.